Notice of General Meeting and Annual Report
03 June 2013
Silence Therapeutics plc (AIM: SLN) announces that its Annual Report & Accounts for the year ended 31 December 2012 and the 2013 Annual General Meeting (AGM) notice were posted to shareholders today. The Annual Report & Accounts for the year ended 31 December 2012 will shortly be available for download at the Company's website www.silence-therapeutics.com
The 2013 AGM will be held at Silence Therapeutics plc, 3 Shortlands Way, London, W6 8DA on 26 June 2013 at 11.00am.
Silence Therapeutics
Ali Mortazavi, chief executive/Timothy Freeborn, finance director +44 (0)333 988 0140
[email protected]
[email protected]
N+1 Singer
Shaun Dobson/Jenny Wyllie
+44 20 7496 3000
[email protected]
[email protected]